Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP147192.RAVNctZlTNAT4C69ABQfB-h0bnNtvrlu_fJ7zmDjw05hg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP147192.RAVNctZlTNAT4C69ABQfB-h0bnNtvrlu_fJ7zmDjw05hg130_assertion type Assertion NP147192.RAVNctZlTNAT4C69ABQfB-h0bnNtvrlu_fJ7zmDjw05hg130_head.
- NP147192.RAVNctZlTNAT4C69ABQfB-h0bnNtvrlu_fJ7zmDjw05hg130_assertion description "[Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147192.RAVNctZlTNAT4C69ABQfB-h0bnNtvrlu_fJ7zmDjw05hg130_provenance.
- NP147192.RAVNctZlTNAT4C69ABQfB-h0bnNtvrlu_fJ7zmDjw05hg130_assertion evidence source_evidence_literature NP147192.RAVNctZlTNAT4C69ABQfB-h0bnNtvrlu_fJ7zmDjw05hg130_provenance.
- NP147192.RAVNctZlTNAT4C69ABQfB-h0bnNtvrlu_fJ7zmDjw05hg130_assertion SIO_000772 19434073 NP147192.RAVNctZlTNAT4C69ABQfB-h0bnNtvrlu_fJ7zmDjw05hg130_provenance.
- NP147192.RAVNctZlTNAT4C69ABQfB-h0bnNtvrlu_fJ7zmDjw05hg130_assertion wasDerivedFrom gad-20150221 NP147192.RAVNctZlTNAT4C69ABQfB-h0bnNtvrlu_fJ7zmDjw05hg130_provenance.
- NP147192.RAVNctZlTNAT4C69ABQfB-h0bnNtvrlu_fJ7zmDjw05hg130_assertion wasGeneratedBy ECO_0000203 NP147192.RAVNctZlTNAT4C69ABQfB-h0bnNtvrlu_fJ7zmDjw05hg130_provenance.